-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate

Benzinga·05/15/2026 23:12:58
Listen to the news
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same period last year.